lifestyle.side.cr

Author: TransMedics Group, Inc.

TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting

April 23, 2026
TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026

April 21, 2026
TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results

February 24, 2026
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

February 20, 2026
TransMedics to Present at Upcoming March Investor Conferences

February 17, 2026
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

February 12, 2026
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial

February 11, 2026
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts

January 12, 2026
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 30, 2025
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

December 24, 2025